Three venture-backed health IT companies completed IPOs in July, ending an almost three-year drought of health IT IPOs. Share prices soared following each IPO, indicative of the enthusiastic response and a desire to see more health IT companies make their way toward public debuts. Composition of revenue, gross margin, and growth are key differentiators between these and all companies and key drivers of valuation. Given the enthusiastic shareholder response to these listings, we
Read More
Research: July Digital Health IPOs, M&A Activity, Public Company Performance Summary
Summary of Health IT/digital IPOs, merger & acquisition (M&A) activity, and public company performance during the month of July.
Digital Health IPOs in July
Source: Healthcare Growth Partners (HGP)
Breaking the digital health IPO drought, there were four initial public offerings (IPOs) during a five-week period from late June to late July, including Livongo, Health Catalyst, Phreesia, and Change Healthcare. The last health IT companies to reach IPO were iRhythym Technologies and
Read More
Health Catalyst IPO Journey: Future Opportunities & Challenges to Watch
Libby Greene, NASDAQ
Last week saw Health Catalyst common stock begin trading on the Nasdaq Global Select Market. This marks the culmination of a journey that started 11 years ago and provides a great illustration of a start-up that has maximized the potential of the move in healthcare to value-based care. However, the IPO comes at a time where there is some uncertainty gripping the markets it targets and there are several key challenges for Health Catalyst to overcome in order to drive
Read More
Global Digital Health VC Funding Breaks $5.1B in First Half of 2019
Global venture capital (VC) funding in digital health/health IT, including private equity and corporate venture capital, reach $5.1 billion in the first half of 2019, according to market research firm Mercom Capital. The 1H and Q2 2019 Digital Health (Healthcare IT) Funding and M&A Report reveals $5.1B in funding across 318 deals compared to $4.9B across 383 deals in 1H 2018. Q2 2019 VC funding held strong at $3.1 billion in 169 deals following the $2 billion raised in 149 deals in Q1 2019.
Read More
Livongo to Offer 10.7 Million Shares in IPO, Priced Between $20 & $23 Per Share
Livongo Health, Inc., today announced it plans to offer 10,700,000 shares of its common stock to the public with the price expected to be between $20.00 and $23.00 per share. Livongo has applied to list its common stock on the Nasdaq Global Select Market under the symbol “LVGO.” Livongo also intends to grant the underwriters a 30-day option to purchase up to an additional 1,605,000 shares of common stock from Livongo.Livongo offers an integrated suite of solutions to promote sustainable health
Read More
Rock Health Report: Is 2019 The Year of the Digital Health IPO?
Digital health funding reached a new record of $4.2 billion across 180 deals in the first half of 2019, according to Rock Health, a full-service venture fund dedicated to digital health. The digital health sector is on track for an $8.4B year in 2019—and may even break 2018’s annual funding total. The report also validates the continued trend of the large $100M+ mega deals, attributing to 30% of venture funding in H1 2019. The 2019 Midyear Digital Health Market Update reflects a maturing digital
Read More
Digital Health Company Livongo Files for $100M IPO
Livongo Health, Inc., today announced that it has publicly filed a registration statement for a proposed initial public offering (IPO) of its common stock, according to the U.S. Securities and Exchange Commission (SEC) filing. Livongo has applied to list its common stock on the Nasdaq Global Select Market under the ticker symbol "LVGO."Livongo Growth MetricsFounded in 2014, Livongo offers an integrated suite of solutions to promote sustainable health behavior change based on easy, real-time data
Read More
Former FDA Commissioner Returns to Venture Capital Firm As Special Partner
Former FDA Commissioner Scott Gottlieb, M.D. is returning to global venture capital firm New Enterprise Associates (NEA) as a Special Partner on the firm’s healthcare investment team. Dr. Gottlieb was a Venture Partner at NEA from 2007 to 2017 before being appointed the 23rd Commissioner of the U.S. Food and Drug Administration (FDA), where he served from 2017 to 2019.Dr. Gottlieb is a physician, policy expert, and advocate for healthcare entrepreneurship, innovation, and access. He is focused
Read More
Mercom: Global Digital Health/Health IT VC Funding Tops $2B in Q1 2019
Global venture capital (VC) funding in digital health/health IT, including private equity and corporate venture capital, reach $2 billion in funding in Q1 2019, according to market research firm Mercom Capital. The Q1 2019 Digital Health (Healthcare IT) Funding and M&A Report reveals $2B in funding across 149 deals compared to $1.4B across 142 deals in Q4 2018. VC funding in Q1 2019 was down 19% compared to the same quarter of last year (Q1 2018) when nearly $2.5 billion was raised in 187
Read More
March 2019 News, Merger & Acquisition, IPO, Public Company Performance Summary
A brief summary of noteworthy news, health IT M&A activity, IPOs, and public company performance during the month of March.
Noteworthy News
Amazon, JP Morgan, Berkshire Names New Joint Venture Haven
Amazon, J.P. Morgan, and Berkshire Hathaway name joint venture Haven. In January 2018, the three founding companies announced plans to create this independent organization, now called Haven, which is free from profit-making incentives and constraints. Haven’s focus is the 1.2 million
Read More